Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood Glucose Response After Oral Intake of Lactulose
2018-002359-14Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lactulose in constipation, sponsored by Fresenius Kabi. Primary endpoint: Capillary blood glucose AUCbaseline_c (0-180 min). Started Sep 2018; status: completed.
02
Drugs
lactulose
03
Conditions
constipation
Beyond the preview
Go deeper on 2018-002359-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002359-14.